FR2379072A1 - Procede et necessaire de dosage, par chromatographie sur colonne, d'une substance pouvant faire l'objet d'une fixation specifique - Google Patents

Procede et necessaire de dosage, par chromatographie sur colonne, d'une substance pouvant faire l'objet d'une fixation specifique

Info

Publication number
FR2379072A1
FR2379072A1 FR7734777A FR7734777A FR2379072A1 FR 2379072 A1 FR2379072 A1 FR 2379072A1 FR 7734777 A FR7734777 A FR 7734777A FR 7734777 A FR7734777 A FR 7734777A FR 2379072 A1 FR2379072 A1 FR 2379072A1
Authority
FR
France
Prior art keywords
ligand
species
medium
reagent
column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7734777A
Other languages
English (en)
French (fr)
Other versions
FR2379072B1 (Direct
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ames Yissum Ltd
Original Assignee
Ames Yissum Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ames Yissum Ltd filed Critical Ames Yissum Ltd
Publication of FR2379072A1 publication Critical patent/FR2379072A1/fr
Application granted granted Critical
Publication of FR2379072B1 publication Critical patent/FR2379072B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7734777A 1977-01-28 1977-11-18 Procede et necessaire de dosage, par chromatographie sur colonne, d'une substance pouvant faire l'objet d'une fixation specifique Granted FR2379072A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL51354A IL51354A (en) 1977-01-28 1977-01-28 Assay method for the quantitative determination of a hapten in aqueous solution

Publications (2)

Publication Number Publication Date
FR2379072A1 true FR2379072A1 (fr) 1978-08-25
FR2379072B1 FR2379072B1 (Direct) 1982-04-09

Family

ID=11049371

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7734777A Granted FR2379072A1 (fr) 1977-01-28 1977-11-18 Procede et necessaire de dosage, par chromatographie sur colonne, d'une substance pouvant faire l'objet d'une fixation specifique

Country Status (11)

Country Link
US (1) US4205058A (Direct)
JP (1) JPS5395697A (Direct)
AU (1) AU510391B2 (Direct)
BR (1) BR7800524A (Direct)
CA (1) CA1091821A (Direct)
DE (1) DE2751588C3 (Direct)
FR (1) FR2379072A1 (Direct)
GB (1) GB1564578A (Direct)
IL (1) IL51354A (Direct)
IT (1) IT1203081B (Direct)
SE (1) SE7714931L (Direct)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342627A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemischer schnelltest
EP0135324A3 (en) * 1983-08-01 1986-07-30 Syva Company Method and means for determination of analytes in a particle-containing medium
EP0304000A1 (de) * 1987-08-19 1989-02-22 Flemming Gmbh Vorrichtung zur Ermittlung eines Antigens oder Antikörpers in einer flüssigen Probe

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014956B1 (de) * 1979-02-20 1982-09-01 Hoechst Aktiengesellschaft Mikrochromatographisches System für Urinproben zur Kontrolle der Arzneimitteleinnahme
US4301139A (en) * 1979-06-21 1981-11-17 Ames-Yissum Ltd. Multilayer column chromatography specific binding assay method, test device and test kit
US4575484A (en) * 1980-05-05 1986-03-11 Montefiore Medical Center, Inc. Binding assay for the detection of mycobacteria
US4489158A (en) * 1980-05-05 1984-12-18 Montefiore Hospital And Medical Center, Inc. Binding assay for the detection of mycobacteria
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4425438A (en) 1981-03-13 1984-01-10 Bauman David S Assay method and device
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4384958A (en) * 1982-02-26 1983-05-24 Owens-Illinois, Inc. Thin layer chromatography device and method of making chromatography test
US4382000A (en) * 1982-02-26 1983-05-03 Owens-Illinois, Inc. Chromatography device and method of making chromatography test
DE3217032C2 (de) * 1982-03-26 1985-04-25 Armin Dipl.-Chem. Dr. rer.nat. 5300 Bonn Gilak Vereinfachtes Separationsverfahren für immunologische Bestimmungen und trockene chromatografische Säule für die Durchführung des Verfahrens
US4456689A (en) * 1982-05-17 1984-06-26 Becton Dickinson And Company Competitive protein binding assay using an organosilane-silica gel separation medium
US4435504A (en) 1982-07-15 1984-03-06 Syva Company Immunochromatographic assay with support having bound "MIP" and second enzyme
GB8305197D0 (en) * 1983-02-24 1983-03-30 Amersham Int Plc Assay methods
USRE34405E (en) * 1983-08-01 1993-10-12 Abbott Laboratories Determination of analytes in particle-containing medium
JPS60235060A (ja) * 1984-05-08 1985-11-21 Dai Ichi Pure Chem Co Ltd 放射性物質を利用した迅速免疫測定法
JPS60133368A (ja) * 1983-12-19 1985-07-16 Dai Ichi Pure Chem Co Ltd 免疫測定方法
US5501949A (en) * 1985-12-10 1996-03-26 Murex Diagnostics Corporation Particle bound binding component immunoassay
US5085988A (en) * 1986-09-05 1992-02-04 Syntex (U.S.A.) Inc. Immunoseparating strip
US4959307A (en) * 1986-09-05 1990-09-25 Syntex (U.S.A.) Inc. Immunoseparating strip
US4963468A (en) * 1986-09-05 1990-10-16 Syntex (U.S.A.) Inc. Immunoseparating strip
US5250412A (en) * 1987-03-23 1993-10-05 Diamedix Corporation Swab device and method for collecting and analyzing a sample
US5256372A (en) * 1987-11-06 1993-10-26 Idexx Corporation Dipstick test device including a removable filter assembly
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5620845A (en) * 1988-06-06 1997-04-15 Ampcor, Inc. Immunoassay diagnostic kit
US5106761A (en) * 1989-03-13 1992-04-21 International Canine Genetics, Inc. Method for detecting molecules in a liquid medium
US5215963A (en) * 1989-10-24 1993-06-01 Berlex Laboratories, Inc. Solubilization and purification of the active gastrin releasing peptide receptor
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
DE69627333T2 (de) 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US6437563B1 (en) 1997-11-21 2002-08-20 Quantum Design, Inc. Method and apparatus for making measurements of accumulations of magnetically susceptible particles combined with analytes
US7713703B1 (en) 2000-11-13 2010-05-11 Biosite, Inc. Methods for monitoring the status of assays and immunoassays
US6194222B1 (en) * 1998-01-05 2001-02-27 Biosite Diagnostics, Inc. Methods for monitoring the status of assays and immunoassays
US6727104B2 (en) * 2001-02-05 2004-04-27 The Board Of Regents Of The University Of Nebraska Microcolumn chromatographic immunoassays
US6720193B2 (en) * 2001-02-05 2004-04-13 Board Of Regents Of The University Of Nebraska Analysis of free analyte fractions by rapid affinity chromatography
CA2467836A1 (en) 2001-11-20 2003-09-04 Duke University Interfacial biomaterials
CA2539288C (en) 2003-09-15 2015-05-12 Shaker A. Mousa Thyroid hormone analogs and methods of use
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
US8071134B2 (en) * 2003-09-15 2011-12-06 Ordway Research Institute, Inc. Thyroid hormone analogs and methods of use
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
JP4727997B2 (ja) * 2005-01-12 2011-07-20 シスメックス株式会社 イムノクロマトグラフィー用キット
US20090022806A1 (en) * 2006-12-22 2009-01-22 Mousa Shaker A Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US20100209382A1 (en) 2005-09-16 2010-08-19 Ordway Research Institute, Inc. Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
WO2008140507A2 (en) * 2006-12-22 2008-11-20 Clf Medical Technology Acceleration Program, Inc. Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
US9180107B2 (en) * 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
CA2765792C (en) 2009-06-17 2017-03-28 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
US10060934B2 (en) 2013-11-18 2018-08-28 Nanopharmaceuticals Llc Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
WO2017214299A1 (en) 2016-06-07 2017-12-14 Nanopharmaceuticals, Llc NON-CLEAVABLE POLYMER CONJUGATED WITH αvβ3 INTEGRIN THYROID ANTAGONISTS
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451777A (en) * 1965-08-20 1969-06-24 Walter Di Giulio Method and apparatus for determining the thyroid hormone content of blood
FR2227533A1 (Direct) * 1973-04-25 1974-11-22 Yissum Res Dev Co

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094647A (en) * 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451777A (en) * 1965-08-20 1969-06-24 Walter Di Giulio Method and apparatus for determining the thyroid hormone content of blood
FR2227533A1 (Direct) * 1973-04-25 1974-11-22 Yissum Res Dev Co

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV896/76 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135324A3 (en) * 1983-08-01 1986-07-30 Syva Company Method and means for determination of analytes in a particle-containing medium
DE3342627A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemischer schnelltest
EP0143412A3 (en) * 1983-11-25 1988-03-30 Boehringer Mannheim Gmbh Immunochemical quick-test
EP0304000A1 (de) * 1987-08-19 1989-02-22 Flemming Gmbh Vorrichtung zur Ermittlung eines Antigens oder Antikörpers in einer flüssigen Probe
WO1989001626A1 (fr) * 1987-08-19 1989-02-23 Flemming Gmbh Procede et dispositif de depistage d'un antigene ou d'un anticorps dans un specimen liquide

Also Published As

Publication number Publication date
IL51354A0 (en) 1977-03-31
IL51354A (en) 1979-07-25
AU3074277A (en) 1979-06-28
JPS5395697A (en) 1978-08-22
BR7800524A (pt) 1978-08-29
CA1091821A (en) 1980-12-16
US4205058A (en) 1980-05-27
DE2751588A1 (de) 1978-08-03
GB1564578A (en) 1980-04-10
SE7714931L (sv) 1978-07-29
AU510391B2 (en) 1980-06-26
DE2751588C3 (de) 1981-01-15
IT1203081B (it) 1989-02-15
DE2751588B2 (de) 1980-04-17
FR2379072B1 (Direct) 1982-04-09

Similar Documents

Publication Publication Date Title
FR2379072A1 (fr) Procede et necessaire de dosage, par chromatographie sur colonne, d'une substance pouvant faire l'objet d'une fixation specifique
FR2458072A1 (fr) Procede, equipement et composition pour l'analyse qualitative et le dosage immuno-enzymatique de substances biologiques
Aherne Immunoassays in the analysis of water
KR890012165A (ko) 이온-포획 분석방법 및 장치
GB1489913A (en) Method and device for the quantitative determination of a substance having a specific binding affinity for another substance
DK0378391T3 (da) Grænseværdi-ligand/receptor-analyse
NO903124D0 (no) Testmetode og reagenssett for denne.
ATE2807T1 (de) Spezifisches bindungsverfahren mit hilfe einer mehrschichtigen saeule, testvorrichtung und testsatz.
FR2422165A1 (fr) Procede et necessaire de dosage d'une substance immunologique par mesure de la lumiere fluorescente emise
FR2436396A1 (fr) Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon
SE7613498L (sv) Forfarande for sammankoppling av biologiska substanser medelst kovalenta bindningar
JPH0619347B2 (ja) 遊離リガンド測定
FR2363109A1 (fr) Nouvelle methode radio-immunologique de dosage de l'hormone thyroidienne et reactif utilise
FI89379B (fi) Bestaemning av glykosylerat hemoglobin i blodet
ATE161104T1 (de) Verfahren und reagenzien zur ausführung von ioneneinfang-digoxin-assays
FR2445527A1 (fr) Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang
DE3586951D1 (de) Festphasendiffusionstextverfahren.
FR2355293A2 (fr) Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique
ES2029114T3 (es) Un metodo para medir la fraccion libre de ligandos en fluidos biologicos.
FR2373795A1 (fr) Dosage immunologique par enzyme fixee
KR950701075A (ko) 생물학적 유체내 리간드의 양을 측정하는 방법 및 이를 수행하기 위한 키트(Method for determination of the amount of a ligand in a biololgical fluid and kit for carrying out such a method)
ATE161332T1 (de) Vorrichtungen zur ausführung von ioneneinfangassays
DE3772254D1 (de) Verfahren zur immunologischen bestimmung der schilddruesenhormone t3 und/oder t4 durch gebrauch des thyroglobulins.
SE7903645L (sv) Gallsyraanalys
ATE77487T1 (de) Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen.

Legal Events

Date Code Title Description
ST Notification of lapse